<DOC>
	<DOCNO>NCT01931657</DOCNO>
	<brief_summary>Hypothesis : Pretreatment mifeprsitone prior Mirena placement induce amenorrhea reduce bleed irrregularities initial month Mirena use .</brief_summary>
	<brief_title>Pretreatment With Mifepristone Prior Mirena Insertion</brief_title>
	<detailed_description>The levonorgestrel release intrauterine system ( IUS ) , Mirena , represent highly effective contraceptive method cost-effective require limited patient effort . Furthermore Mirena offer numerous noncontraceptive benefit address different medical need woman reproductive non reproductive age . Side effect menstrual abnormality important reason early discontinuation contraceptive method . Irregular bleeding pattern spot represent well know adverse effect first month use Mirena corresponds important factor negatively influence acceptability IUS . Up today standard treatment suggest resolve issue . By induce amenorrhea within short period treatment anti-progesterone , mifepristone , prior insertion Mirena , bleed irregularity first month use might reduce could therefore represent important strategy increase acceptability contraceptive system . The purpose present study evaluate bleeding pattern first month use Mirena patient treat mifepristone compare placebo woman use Mirena contraception . The study also address effect mifepristone endometrial morphology breast tissue .</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Inclusion criterion : Premenopausal woman , &gt; /= 18 year age . Desire Mirena contraception Good general health ( judge ; general physical examination Willing able participate give informed consent Exclusion criterion : Any hormonal treatment IUD use within 2 month prior study start History malignant disorder breast Any contraindication mifepristone Pregnancy breast feeding within 2 month prior study start</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>LNG-IUS</keyword>
	<keyword>Mirena</keyword>
	<keyword>Contraception</keyword>
	<keyword>Bleeding</keyword>
	<keyword>Hormonal effect breast</keyword>
</DOC>